SCHEMBL28737751

SCHEMBL28737751

CC(C)S(=O)(=O)c1cccc(OC[C@H](O)COC(N)=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
KDM4E B2RXH2 2/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NR1H2 P55055 2/20 0.40
NR1H3 Q13133 2/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HIF1A Q16665 1/20 0.40
KAT6A Q92794 1/20 0.40
ADRB2 P07550 4/20 0.39
ADRB1 P08588 4/20 0.39
ADRB3 P13945 3/20 0.38
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CNR1 P21554 1/20 0.37
ADRA1D P25100 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737753 1.00 CYP1A2 (0.50) CYP1A2KDM4ELMNASMN1; SMN2NR1H2
SCHEMBL28737943 0.88 CYP1A2 (0.52) CYP1A2KDM4ELMNASMN1; SMN2NR1H2
SCHEMBL28737942 0.88 CYP1A2 (0.52) CYP1A2KDM4ELMNASMN1; SMN2NR1H2
SCHEMBL28738065 0.88 CYP1A2 (0.52) CYP1A2KDM4ELMNASMN1; SMN2NR1H2
SCHEMBL28470108 0.84 CYP1A2 (0.49) CYP1A2KDM4ELMNASMN1; SMN2TSHR
SCHEMBL28470107 0.84 CYP1A2 (0.49) CYP1A2KDM4ELMNASMN1; SMN2TSHR
SCHEMBL28737765 0.81 CYP1A2 (0.48) CYP1A2KDM4ELMNASMN1; SMN2MAPK1
SCHEMBL28737763 0.81 CYP1A2 (0.48) CYP1A2KDM4ELMNASMN1; SMN2MAPK1
SCHEMBL28737773 0.79 KAT6A (0.42) KDM4ELMNANR1H2NR1H3TSHR
SCHEMBL28737851 0.79 ADRB3 (0.47) CYP1A2KDM4ELMNASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed